Cargando…

SLC25A11 serves as a novel prognostic biomarker in liver cancer

Liver cancer is a disease with high mortality; it is often diagnosed at intermediate and advanced stages and has a high recurrence rate. ROS restriction and adequate energy supply play significant roles in liver cancer. SLC25A11, a member of the malate-aspartate shuttle (MAS), regulates electroneutr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Guoqiang, Wang, Ruobing, Jia, Shengnan, Li, Yanqing, Jiao, Yan, Liu, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303164/ https://www.ncbi.nlm.nih.gov/pubmed/32555317 http://dx.doi.org/10.1038/s41598-020-66837-6

Ejemplares similares

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)

The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer
por: Wang, Ruobing, et al.
Publicado: (2020)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

PGM5: a novel diagnostic and prognostic biomarker for liver cancer
por: Jiao, Yan, et al.
Publicado: (2019)

The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer
por: Jiao, Yan, et al.
Publicado: (2020)

SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma
por: Yang, Meng-Ling, et al.
Publicado: (2021)

HN1 as a diagnostic and prognostic biomarker for liver cancer
por: Liu, Zhicheng, et al.
Publicado: (2020)

A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer
por: Li, He, et al.
Publicado: (2022)

A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
por: Qian, Li, et al.
Publicado: (2022)

SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer
por: Long, Lin, et al.
Publicado: (2018)

RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression
por: Fu, Chunhong, et al.
Publicado: (2021)

SNAP25 is a potential prognostic biomarker for prostate cancer
por: Di, Longjiang, et al.
Publicado: (2022)

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer
por: Sun, Tianshui, et al.
Publicado: (2020)

OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients
por: Jiao, Yan, et al.
Publicado: (2019)

SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma
por: Fan, Zhongyi, et al.
Publicado: (2022)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer
por: Wang, Feng-Jiao, et al.
Publicado: (2021)

Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver
por: González-Moreno, Luis, et al.
Publicado: (2023)

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
por: Zhen, Jing, et al.
Publicado: (2023)

UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer
por: Sun, Qiran, et al.
Publicado: (2023)

ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19
por: Yang, Wuping, et al.
Publicado: (2021)

Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
por: Lee, Jae-Seon, et al.
Publicado: (2019)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma
por: Liu, Shuochen, et al.
Publicado: (2023)

Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy
por: Rochette, Luc, et al.
Publicado: (2020)

Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma
por: Fang, Xiangming, et al.
Publicado: (2023)

Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene SLC7A11 as a Prognostic Biomarker for Cancer
por: Lin, Yi, et al.
Publicado: (2022)

Exosomal Long Non-coding RNAs Serve as Biomarkers for Liver Disease
por: Yang, Zixuan, et al.
Publicado: (2023)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

A distinctively expressed long noncoding RNA, RP11‐466I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma
por: Zhang, Junyong, et al.
Publicado: (2018)

Hypoxia–Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple Myeloma
por: Li, Wenjin, et al.
Publicado: (2022)

Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancer
por: Li, Qi-jia, et al.
Publicado: (2022)

Serum Circular FoxO3a Serves as a Novel Prognostic Biomarker in Squamous Cervical Cancer
por: Tang, Xiaoyan, et al.
Publicado: (2020)

Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia
por: Li, Fenglin, et al.
Publicado: (2023)

G-rich sequence factor 1 serves as a prognostic biomarker in septic patients
por: Qi, Lei, et al.
Publicado: (2021)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

Ancient genes can be served as pan‐cancer diagnostic and prognostic biomarkers
por: Ji, Xiangwen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rvdhnbv3healsie1qvfp21biv5